The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

31, 2025 – The FDA has approved a new non-opioid oral drug for acute pain in adults ... and herbal supplements – before starting their treatment to avoid possible interactions.

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to ...